CD276 and bladder transitional cell carcinoma: The Kaplan-Meier database was employed, and the results obtained showed that CD276 expression was lower in the BLCA, HNSC, CESC, KIRC, KIRP, LIHC, LUAD, PAAD and PCPG cancer types, indicating was CD276 presented a hazard for patients (Fig. 8).